Biofrontera Inc. — Investor Relations & Filings
Filings indexed
350
across all filing types
Latest filing
2026-03-19
Annual Report
Country
US
United States of America
Listing
US
BFRI
Biofrontera Inc. is a biopharmaceutical company that commercializes a portfolio of pharmaceutical products for the treatment of dermatological conditions. The company specializes in photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used to treat actinic keratoses, a type of pre-cancerous skin lesion, and impetigo, a bacterial skin infection. Biofrontera focuses on establishing PDT as a standard of care in dermatology and utilizes a proprietary nanoemulsion technology to improve the stability and skin penetration of its formulations, potentially increasing clinical efficacy.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-K - Biofrontera Inc. (0001858685) (Filer) | 2026-03-19 | English | |
| 8-K - Biofrontera Inc. (0001858685) (Filer) | 2026-03-19 | English | |
| 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | |
| 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | |
| 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | |
| 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 32989302 | 10-K - Biofrontera Inc. (0001858685) (Filer) | 2026-03-19 | English | ||
| 32986713 | 8-K - Biofrontera Inc. (0001858685) (Filer) | 2026-03-19 | English | ||
| 32911294 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911293 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911292 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911288 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911287 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911284 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32911281 | 4 - Biofrontera Inc. (0001858685) (Issuer) | 2026-03-07 | English | ||
| 32899942 | 8-K - BIOFRONTERA INC. (0001858685) (Filer) | 2026-02-26 | English | ||
| 32100293 | SCHEDULE 13G/A Filing | 2026-02-11 | English | ||
| 32100370 | 8-K Filing | 2026-02-09 | English | ||
| 32100337 | SCHEDULE 13G/A Filing | 2026-01-28 | English | ||
| 13442747 | 8-K | 2026-01-13 | English | ||
| 13442785 | 8-K | 2026-01-07 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
BIONEERCORPORATION
Develops and manufactures molecular biology products for re…
|
064550 | KR | Manufacturing |
|
BioNTech SE
Biotechnology company developing immunotherapies for cancer…
|
BNTX | DE | Manufacturing |
|
BioNxt Solutions Inc.
Clinical-stage developer of next-generation drug formulatio…
|
BNXT | CA | Manufacturing |
|
Biophage Pharma Inc.
Developing innovative phage-based therapies for antibiotic-…
|
BIPMF | CA | Manufacturing |
|
BioPorto
An in vitro diagnostics company specializing in biomarkers …
|
BIOPOR | DK | Manufacturing |
|
BIO-RAD LABORATORIES, INC.
Develops and manufactures products for life science and cli…
|
BIO | US | Manufacturing |
|
Biosergen AB
Develops drugs to treat severe and resistant invasive funga…
|
BIOSGN | SE | Manufacturing |
|
Biosino Bio-Technology and Science Incorporation
Major high-tech manufacturer of in-vitro diagnostic (IVD) p…
|
8247 | HK | Manufacturing |
|
Bio Solution Co.,Ltd.
Develops cell therapies, human tissue models, and bio-labor…
|
086820 | KR | Manufacturing |
|
BioSyent Inc.
Specialty pharmaceutical company developing and commerciali…
|
RX | CA | Manufacturing |
Biofrontera Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35198/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35198 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35198 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35198 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35198}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Biofrontera Inc. (id: 35198)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.